Silva, J.Q.d.; Moraes, N.V.d.; Estrela, R.; Coelho, D., Jr.; Feriani, D.; Migotto, K.; Caruso, P.; Silva, I.L.F.e.; Oliveira, D.d.A.; Telles, J.P.;
et al. Amikacin Dosing Adjustment in Critically Ill Oncologic Patients: A Study with Real-World Patients, PBPK Analysis, and Digital Twins. Pharmaceutics 2025, 17, 297.
https://doi.org/10.3390/pharmaceutics17030297
AMA Style
Silva JQd, Moraes NVd, Estrela R, Coelho D Jr., Feriani D, Migotto K, Caruso P, Silva ILFe, Oliveira DdA, Telles JP,
et al. Amikacin Dosing Adjustment in Critically Ill Oncologic Patients: A Study with Real-World Patients, PBPK Analysis, and Digital Twins. Pharmaceutics. 2025; 17(3):297.
https://doi.org/10.3390/pharmaceutics17030297
Chicago/Turabian Style
Silva, Juliana Queiroz da, Natália Valadares de Moraes, Rita Estrela, Diogenes Coelho, Jr., Diego Feriani, Karen Migotto, Pedro Caruso, Ivan Leonardo França e Silva, Daiane de Araujo Oliveira, João Paulo Telles,
and et al. 2025. "Amikacin Dosing Adjustment in Critically Ill Oncologic Patients: A Study with Real-World Patients, PBPK Analysis, and Digital Twins" Pharmaceutics 17, no. 3: 297.
https://doi.org/10.3390/pharmaceutics17030297
APA Style
Silva, J. Q. d., Moraes, N. V. d., Estrela, R., Coelho, D., Jr., Feriani, D., Migotto, K., Caruso, P., Silva, I. L. F. e., Oliveira, D. d. A., Telles, J. P., & Moreira, F. d. L.
(2025). Amikacin Dosing Adjustment in Critically Ill Oncologic Patients: A Study with Real-World Patients, PBPK Analysis, and Digital Twins. Pharmaceutics, 17(3), 297.
https://doi.org/10.3390/pharmaceutics17030297